Recombinant Human GbL Protein，His

GbL, or glucan-binding lectin, is a type of recombinant protein that has gained significant interest in the fields of biochemistry and molecular biology due to its potential applications in various medical and agricultural domains. Initially discovered in certain fungal species, GbL exhibits a unique ability to bind to specific polysaccharides, particularly beta-glucans, which are essential components of the cell walls of many fungi and plants. This binding activity has led researchers to explore GbL's roles in immune response modulation, pathogen recognition, and as a potential therapeutic agent. The ability to produce GbL through recombinant DNA technology has enabled scientists to study its properties in detail and increase its availability for experimental and commercial applications. Moreover, understanding the structure-function relationship of GbL can illuminate mechanisms of pathogen-host interactions, thus providing insights into developing novel strategies for disease prevention and treatment. Additionally, as a lectin, GbL's interactions with glycosylated molecules are of great relevance in glycomics research, making it a valuable tool for studying carbohydrate-protein interactions. Overall, the study of GbL and its recombinant forms is paving the way for advancements in biotechnology, with implications that extend from immunology to agricultural pest control.